Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation

Details for Australian Patent Application No. 2005254998 (hide)

Owner ZymoGenetics, Inc.

Inventors Billsborough, Janine; Gao, Zeren; Kuestner, Rolf E.; Presnell, Scott R.; Levin, Steven D.; Jaspers, Stephen R.; Burkhead, Steven K.

Agent Spruson & Ferguson

Pub. Number AU-B-2005254998

PCT Pub. Number WO2005/123778

Priority 60/578,805 10.06.04 US

Filing date 10 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 27 October 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/123778 Priority application(s): WO2005/123778

27 October 2011 Application Accepted

  Published as AU-B-2005254998

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005255011-Heterocyclic derivatives for treatment of hyperlipidemia and related diseases

2005254993-Plastid transit peptides